HAEMOPHILIA A WITH INHIBITORS
Clinical trials for HAEMOPHILIA A WITH INHIBITORS explained in plain language.
Never miss a new study
Get alerted when new HAEMOPHILIA A WITH INHIBITORS trials appear
Sign up with your email to follow new studies for HAEMOPHILIA A WITH INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Long-Term treatment aims to stop bleeds in haemophilia patients
Disease control OngoingThis study is testing the long-term safety and effectiveness of a new medicine called Mim8 for people with haemophilia A. Mim8 is designed to prevent bleeding episodes by helping the blood to clot. The study will follow participants for up to 5.5 years to see how well the treatme…
Matched conditions: HAEMOPHILIA A WITH INHIBITORS
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Apr 02, 2026 09:12 UTC
-
Daily shot aims to stop dangerous bleeds in complex haemophilia
Disease control OngoingThis study is testing a new medicine called concizumab to see if it can safely prevent bleeding episodes in people with haemophilia A or B who have developed inhibitors. Participants will give themselves a daily injection under the skin at home for up to seven years. The goal is …
Matched conditions: HAEMOPHILIA A WITH INHIBITORS
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Apr 02, 2026 09:11 UTC